Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Treated for Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01572987
What this trial is testing

Endoscopic Resection or Ablation for Patients With Dysplasia or Cancer Requiring Treatment of Barrett's Esophagus

Who this might be right for
Barrett's EsophagusEsophageal Neoplasms
Midwest Biomedical Research 12
Not applicableLooking for participantsNCT07759193
What this trial is testing

Energy Expenditure Assessment in Head and Neck Cancer Patients Treated With Free Flap Surgery

Who this might be right for
Reconstructive Surgical ProceduresFree Tissue FlapsHead and Neck Cancer+1 more
Tel-Aviv Sourasky Medical Center 19
Post-approval studies (Phase 4)Study completedNCT01794793
What this trial is testing

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Who this might be right for
Cushing's DiseaseAcromegalyNeuroendocrine Tumors+6 more
RECORDATI GROUP 337
Testing effectiveness (Phase 2)Study completedNCT01055314
What this trial is testing

Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma

Who this might be right for
Adult RhabdomyosarcomaChildhood Alveolar RhabdomyosarcomaChildhood Embryonal Rhabdomyosarcoma+3 more
National Cancer Institute (NCI) 175
Not applicableStudy completedNCT01271738
What this trial is testing

Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerBreast Tumors+4 more
Emory University 79
Large-scale testing (Phase 3)UnknownNCT03598348
What this trial is testing

Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Huazhong University of Science and Technology 288
Testing effectiveness (Phase 2)Active Not RecruitingNCT04482309
What this trial is testing

T-DXd in Patients With Selected HER2 Expressing Tumors

Who this might be right for
Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal CancerPart 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
AstraZeneca 477
Early research (Phase 1)Ended earlyNCT00573404
What this trial is testing

Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumor
Vanderbilt-Ingram Cancer Center 6
Not applicableNot Yet RecruitingNCT07054047
What this trial is testing

Improving Diagnosis and Treatment for Patients With Rectal Cancer

Who this might be right for
GI Cancer
Imperial College London 438
Testing effectiveness (Phase 2)Ended earlyNCT01383447
What this trial is testing

Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Who this might be right for
Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic LeukemiaRecurrent Adult Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 2
Testing effectiveness (Phase 2)Study completedNCT00030264
What this trial is testing

Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1Precancerous Condition
Children's Hospital of Philadelphia 23
Not applicableUnknownNCT04742998
What this trial is testing

Task of Acoustic-phonetic Decoding on Anatomic Deficits in Paramedical Assessment of Speech Disorders for Patients Treated for Oral or Oropharyngeal Cancer

Who this might be right for
Speech Intelligibility
University Hospital, Toulouse 116
Not applicableEnded earlyNCT01045226
What this trial is testing

Proton Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Abramson Cancer Center at Penn Medicine 300
Not applicableUnknownNCT03776578
What this trial is testing

Oral Cancer With Wide Excision and Free Flap Reconstruction

Who this might be right for
Head and Neck Cancer
National Taiwan University Hospital 80
Early research (Phase 1)UnknownNCT04756934
What this trial is testing

HX008 Plus LP002 for the Treatment of Patients With Advanced Melanoma

Who this might be right for
Melanoma
Taizhou HoudeAoke Biomedical Co., Ltd. 63
Testing effectiveness (Phase 2)Study completedNCT00576199
What this trial is testing

Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancer

Who this might be right for
Liver Cancer
Hoffmann-La Roche 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05826964
What this trial is testing

Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

Who this might be right for
Breast CancerER-positive Breast CancerHER2-negative Breast Cancer+1 more
University of Miami 24
Early research (Phase 1)Active Not RecruitingNCT03635632
What this trial is testing

C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaRelapsed Osteosarcoma+4 more
Baylor College of Medicine 94
Testing effectiveness (Phase 2)Study completedNCT00553098
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders

Who this might be right for
Immunodeficiency SyndromeNon-Cancer Diagnosis
Fred Hutchinson Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT00817284
What this trial is testing

Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Ulrik Lassen 60
Next Page